Compliance and internal controls: Bringing the two worlds together

Anna Giedrys, Head Global Compliance and Control Development, Novartis Business Services, gave the presentation “Compliance and Internal Controls: Bringing the two worlds together” at last year’s Pharma Engagement Live event. Download and Learn: Development control matrix Simply complexity Control activity References DCM self assessment Control maturity level DCM the results 2 years on Download Presentation Found this interesting? You might …

Effective third party due diligence for pharma companies: understanding current trends and issues

At the 2014 Pharma Compliance Europe event, Michael Harris, Head of Enhanced Due Dilligance-EMEA, Thomson Reuters, gave the presentation “Effective third party due diligence for Pharma companies: understanding current trends and issues.” Download and learn: Who are we dealing with? Detailed accurate reliable intelligence Types of risks faced in the pharma and medical device industry in China Top countries for enhanced …

Collaboration between Internal Audit and Compliance

At last year’s Pharma Compliance Europe event, Peter Elam, Head of Internal Audit, Novartis, gave the presentation “Collaboration between Internal Audit and Compliance.” Download and learn: Global Novartis compliance framework Risk assdessment and monitoring Reversing the “Three Lines of Defense” Progression in relationship between functions Download Presentation Found this interesting? You might also be interested in our Pharma Compliance Europe …

The Sunshine Act Overview

At last year’s Pharma Compliance Europe event, Katrina Cahill, Associate Director, Compliance Global Transparency Lead, Biogen Idec, gave the presentation “The Sunshine Act Overview.” Download and learn; The rationale Current US transparency landscape US sunshine Act: High level requirements Overview of general payments and search reports Preparedness Reciepts and transactions Aggregation and reporting Communication Current state What is next? Download …

EFPIA/HCP/HCO transfer of value disclosure requirements: Implementation and challenges within a multi national company

Dr Marcel Koerting, Senior legal and Compliance Council, Novo Noridsk Healthcare AG, gave the presentation “EFPIA/HCP/HCO transfer of value disclosure requirements: Implementation and challenges within a multi national company” at last year’s Pharma Compliance Europe event. Download and learn: Novo Nordisk overview EFPIA disclosure code Key challenges Download Presentation Found this interesting? You might also be interested in our Pharma Compliance Europe …

Taking control of your global compliance ecosystem

At last year’s Pharma Compliance 2014 event, Greg Maynard, Director, Transparency and Disclosure Solutions, Health Market Science, gave a presentation “Taking control of your global compliance ecosystem.” Download and learn: Elements of a global transparency program Data Sourcing Data management Recipient profile data privacy data governing reporting Download Presentation Found this interesting? You might also be interested in our Pharma …

Developing clear and structured monitoring strategies that minimise risks and optimise compliance success rates.

Last year at the Pharma Compliance Europe 2014 event, Karolina Czernicka-Kuhl,  Head of Legal and Compliance, Novo Nordisk, gave the presentation “Developing clear and structured monitoring strategies that minimise risks and optimise compliance success rates.” Download and learn: Why monitoring? What should be monitored? How to monitor (who should monitor)? Benefits and costs Download Presentation Found this interesting? You might also …

Out with the old for cancer treatment?

Today is #WorldCancerDay and it strikes me that it is great to see all of the developments in cancer treatments within the scientific community. The way in which we develop medicines is changing, and now everywhere you look you see information about ‘personalised’ or ‘precision’ medicine. One of the areas which is being hailed as a key disease group which …